BioSpace News Archive

Universal PropTech Inc. (TSXV: UPI.H) (“UPI” or the “Company”) is pleased to announce that it and Xemoto Media Ltd. (“Xemoto”) have received conditional approval from the Canadian Securities Exchange

Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company developing N-myristoyltransferase (NMT) inhibitors to treat hematologic cancers and solid tumors.

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC), today announced the publication of its scholarly article, “Lasofoxifene as a Potential Treatment for Aromatase Inhibitor-Resistant ER-Positive Breast Cancer,” in the peer-reviewed journal Breast Cancer Research.

Glucotrack, Inc., a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced that it will participate in the Sidoti Small Cap Investor Conference.

A new study guided by a renowned surgeon at City of Hope®, one of the largest cancer research and treatment organizations in the United States, demonstrates that robotic liver surgery can be a safe, outpatient procedure.

The U.S. Department of Justice and the U.S. Food and Drug Administration announced the creation of a federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes.

Arcutis Biotherapeutics, Inc. announced new results from the INTEGUMENT-OLE long-term open-label study of investigational once-daily roflumilast cream 0.15% in adults and children ages 6 years and older with AD presented at the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference.

Hudson Therapeutics announced that Shaperon, an innovative biopharmaceutical company specializing in immune therapeutics, has signed a Memorandum of Understanding with Dong-A ST for the development of nanobody-based new drugs.